Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Unlocking Sustainable Weight Loss with GLP1 Medications and Peptides at Illume Med Spa & Wellness Apr 18, 2025 2 min read In the evolving landscape of weight management, GLP-1 receptor agonists and peptides have emerged as transformative tools
A 2025 hospital-based case-control study found that each one-unit increase in the MIND diet score was associated with a 47% lower odds of endometriosis, and high adherence to the MIND diet was associated with an 83% lower odds of endometriosis compared to lower adherence after adjustment for confounders
Pilot clinical studies and case reports describe nausea in 65% of subjects at doses above 0,5 mg (resolution 2-4 h post-injection), flushing in 55%, transient increases in blood pressure and tachycardia in 40-60% of subjects, with peak acute effects occurring 90-120 minutes post-dose
Filiano AJ, Xu Y, Tustison NJ, Marsh RL, Baker W, Smirnov I, et al
